Author: Hongyi Chen; Zhicheng Zhang; Li Wang; Zhihua Huang; Fanghua Gong; Xiaodong Li; Yahong Chen; Jinzi J. WU
Title: First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients Document date: 2020_3_24
ID: b3y9zxjr_24
Snippet: The vital sign of the patient showed body temperature (BT) of 36.4℃ and oxygen saturation (SPO 2 ) of 99% under ambient air. The breathing sound was normal initially. She had no other underlying disease before this onset. ï¬ In the morning of February 20, she was given the first dose of danoprevir boosted by ritonavir, along with interferon nebulization. ï¬ On February 20, both lower lungs showed multiple diffuse patch-shape areas and ground-.....
Document: The vital sign of the patient showed body temperature (BT) of 36.4℃ and oxygen saturation (SPO 2 ) of 99% under ambient air. The breathing sound was normal initially. She had no other underlying disease before this onset. ï¬ In the morning of February 20, she was given the first dose of danoprevir boosted by ritonavir, along with interferon nebulization. ï¬ On February 20, both lower lungs showed multiple diffuse patch-shape areas and ground-glass opacity (GGO), especially obvious in the left lower lung, based on chest CT scans ( Figure 2A ).
Search related documents:
Co phrase search for related documents- CT scan and ground glass: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- GGO ground glass opacity and ground glass: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- GGO ground glass opacity and ground glass opacity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- GGO ground glass opacity and oxygen saturation: 1, 2
- ground glass and low lung: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- ground glass and oxygen saturation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61
- ground glass opacity and low lung: 1
- ground glass opacity and oxygen saturation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- interferon nebulization and patch shape: 1, 2
- interferon nebulization and patient vital sign: 1
- interferon nebulization and vital sign: 1
- left low lung and low lung: 1, 2
- left low lung and oxygen saturation: 1
- low lung and oxygen saturation: 1, 2, 3, 4, 5, 6, 7, 8, 9
- oxygen saturation and patient vital sign: 1
- oxygen saturation and vital sign: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- patch shape and patient vital sign: 1
- patch shape and vital sign: 1
- patient vital sign and vital sign: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
Co phrase search for related documents, hyperlinks ordered by date